{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:13:44Z","timestamp":1790802824873,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Servier Brazil"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiol Ther"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s40119-025-00405-9","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T13:32:18Z","timestamp":1745933538000},"page":"249-265","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effectiveness and Tolerability of Trimetazidine 80\u00a0mg Once Daily in Patients with Chronic Coronary Syndrome in Brazil: The V-GOOD Observational Study"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6785-7506","authenticated-orcid":false,"given":"Lu\u00eds Henrique Wolff","family":"Gowdak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6723-5758","authenticated-orcid":false,"given":"Paulo Magno Martins","family":"Dourado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1187-8690","authenticated-orcid":false,"given":"Dalton Bertolim","family":"Pr\u00e9coma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6243-8855","authenticated-orcid":false,"given":"C\u00e9sar","family":"de Oliviera Lopes Dusilek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6765-6433","authenticated-orcid":false,"given":"Francisco Maia","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6583-6536","authenticated-orcid":false,"given":"Juan Carlos","family":"Yugar-Toledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8933-5725","authenticated-orcid":false,"given":"Felipe Montes","family":"Pena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domingos Ant\u00f4nio","family":"de Almeida Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8621-0305","authenticated-orcid":false,"given":"Elizabeth","family":"do Esp\u00edrito Santo Cest\u00e1rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Olavo Raimundo","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8585-7940","authenticated-orcid":false,"given":"Conrado Roberto Hoffmann","family":"Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Filinto","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7696-5410","authenticated-orcid":false,"given":"Fl\u00e1vio","family":"de Souza Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5831-609X","authenticated-orcid":false,"given":"Gerez Fernandes","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1392-6817","authenticated-orcid":false,"given":"Victor Rodrigues Ribeiro","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9253-8775","authenticated-orcid":false,"given":"Marcella Chaves","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayara L\u00eddia","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the V-GOOD Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"issue":"5","key":"405_CR1","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1177\/0003319718796313","volume":"70","author":"G Ambrosio","year":"2019","unstructured":"Ambrosio G, Collins P, Dechend R, Lopez-Sendon J, Manolis AJ, Camm AJ. StaBle Angina: PeRceptIon of NeeDs, Quality of Life and ManaGemEnt of Patients (BRIDGE Study)\u2014a multinational European physician survey. Angiology. 2019;70(5):397\u2013406.","journal-title":"Angiology"},{"issue":"16","key":"405_CR2","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1001\/archinternmed.2009.295","volume":"169","author":"JF Beltrame","year":"2009","unstructured":"Beltrame JF, Weekes AJ, Morgan C, Tavella R, Spertus JA. The prevalence of weekly angina among patients with chronic stable angina in primary care practices: the Coronary Artery Disease in General Practice (CADENCE) study. Arch Intern Med. 2009;169(16):1491\u20139.","journal-title":"Arch Intern Med"},{"issue":"1","key":"405_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1378\/chest.13-2885","volume":"146","author":"GR Geovanini","year":"2014","unstructured":"Geovanini GR, Gowdak LHW, Pereira AC, Danzi-Soares NJ, Dourado LOC, Poppi NT, et al. OSA and depression are common and independently associated with refractory angina in patients with coronary artery disease. Chest. 2014;146(1):73\u201380.","journal-title":"Chest"},{"issue":"9","key":"405_CR4","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","volume":"148","author":"SS Virani","year":"2023","unstructured":"Virani SS, Newby LK, Arnold SV, Bittner V, Brewer LC, Demeter SH, et al. 2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2023;148(9):e9\u2013119.","journal-title":"Circulation"},{"issue":"29","key":"405_CR5","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1093\/eurheartj\/ehy857","volume":"40","author":"F Crea","year":"2019","unstructured":"Crea F, Bairey Merz CN, Beltrame JF, Berry C, Camici PG, Kaski JC, et al. Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization. Eur Heart J. 2019;40(29):2455\u201362.","journal-title":"Eur Heart J"},{"issue":"10115","key":"405_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(17)32714-9","volume":"391","author":"R Al-Lamee","year":"2018","unstructured":"Al-Lamee R, Thompson D, Dehbi HM, Sen S, Tang K, Davies J, et al. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. Lancet. 2018;391(10115):31\u201340.","journal-title":"Lancet"},{"issue":"10325","key":"405_CR7","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S0140-6736(21)02045-6","volume":"399","author":"WE Boden","year":"2022","unstructured":"Boden WE, Kaski JC, Al-Lamee R, Weintraub WS. What constitutes an appropriate empirical trial of antianginal therapy in patients with stable angina before referral for revascularisation? Lancet. 2022;399(10325):691\u20134.","journal-title":"Lancet"},{"issue":"293","key":"405_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ijcard.2019.05.063","volume":"15","author":"M Marzilli","year":"2019","unstructured":"Marzilli M, Vinereanu D, Lopaschuk G, Chen Y, Dalal JJ, Danchin N, et al. Trimetazidine in cardiovascular medicine. Int J Cardiol. 2019;15(293):39\u201344.","journal-title":"Int J Cardiol"},{"issue":"203","key":"405_CR9","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.ijcard.2015.11.060","volume":"15","author":"YM Lopatin","year":"2016","unstructured":"Lopatin YM, Rosano GM, Fragasso G, Lopaschuk GD, Seferovic PM, Gowdak LH, et al. Rationale and benefits of trimetazidine by acting on cardiac metabolism in heart failure. Int J Cardiol. 2016;15(203):909\u201315.","journal-title":"Int J Cardiol"},{"issue":"3","key":"405_CR10","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.ijcard.2014.10.149","volume":"177","author":"S Peng","year":"2014","unstructured":"Peng S, Zhao M, Wan J, Fang Q, Fang D, Li K. The efficacy of trimetazidine on stable angina pectoris: a meta-analysis of randomized clinical trials. Int J Cardiol. 2014;177(3):780\u20135.","journal-title":"Int J Cardiol"},{"key":"405_CR11","doi-asserted-by":"crossref","unstructured":"Chazov EI, Lepakchin VK, Zharova EA, Fitilev SB, Levin AM, Rumiantzeva EG, et al. Trimetazidine in angina combination therapy\u2014the TACT study: trimetazidine versus conventional treatment in patients with stable angina pectoris in a randomized, placebo-controlled, multicenter study. Am J Ther. 2005;12(1):35\u201342.","DOI":"10.1097\/00045391-200501000-00006"},{"issue":"24","key":"405_CR12","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1053\/euhj.2001.2896","volume":"22","author":"H Szwed","year":"2001","unstructured":"Szwed H, Sadowski Z, Elikowski W, Koronkiewicz A, Mamcarz A, Orszulak W, et al. Combination treatment in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study (TRIMPOL II). TRIMetazidine in POLand. Eur Heart J. 2001;22(24):2267\u201374.","journal-title":"Eur Heart J"},{"key":"405_CR13","doi-asserted-by":"crossref","unstructured":"Detry JM, Sellier P, Pennaforte S, Cokkinos D, Dargie H, Mathes P. Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Trimetazidine European Multicenter Study Group. Br J Clin Pharmacol. 1994;37(3):279\u201388.","DOI":"10.1111\/j.1365-2125.1994.tb04276.x"},{"issue":"36","key":"405_CR14","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","volume":"45","author":"C Vrints","year":"2024","unstructured":"Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J, et al. 2024 ESC guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45(36):3415\u2013537.","journal-title":"Eur Heart J"},{"issue":"2 Suppl 2","key":"405_CR15","first-page":"1","volume":"103","author":"LA Cesar","year":"2014","unstructured":"Cesar LA, Ferreira JF, Armaganijan D, Gowdak LH, Mansur AP, Bodanese LC, et al. Guideline for stable coronary artery disease. Arq Bras Cardiol. 2014;103(2 Suppl 2):1\u201356.","journal-title":"Arq Bras Cardiol"},{"issue":"3","key":"405_CR16","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/eurheartj\/ehz660","volume":"41","author":"E Sorbets","year":"2020","unstructured":"Sorbets E, Fox KM, Elbez Y, Danchin N, Dorian P, Ferrari R, et al. Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry. Eur Heart J. 2020;41(3):347\u201356.","journal-title":"Eur Heart J"},{"key":"405_CR17","doi-asserted-by":"crossref","unstructured":"Frishman WH. Importance of medication adherence in cardiovascular disease and the value of once-daily treatment regimens. Cardiol Rev. 2007;15(5):257\u201363.","DOI":"10.1097\/CRD.0b013e3180cabbe7"},{"key":"405_CR18","doi-asserted-by":"crossref","unstructured":"Pozdnyakov YM, On Behalf of the Study Investigators. Clinical acceptability of trimetazidine modified-release 80 mg once daily versus trimetazidine modified-release 35 mg twice daily in stable angina pectoris. Cardiol Ther. 2018;7(1):61\u201370.","DOI":"10.1007\/s40119-018-0110-5"},{"key":"405_CR19","doi-asserted-by":"crossref","unstructured":"Glezer MG, Vygodin VA, Investigators ODA. Anti-anginal effectiveness and tolerability of trimetazidine modified release 80 mg once daily in stable angina patients in real-world practice. Adv Ther. 2018;35(9):1368\u201377.","DOI":"10.1007\/s12325-018-0756-3"},{"key":"405_CR20","doi-asserted-by":"crossref","unstructured":"Lopatin Y, Petrova P, Investigators MV. Effectiveness and tolerability of trimetazidine 80 mg once daily in patients with stable angina uncontrolled with bisoprolol-based therapy: the Modus Vivendi observational study. Cardiol Ther. 2022;11(1):93\u2013111.","DOI":"10.1007\/s40119-021-00249-z"},{"issue":"1","key":"405_CR21","doi-asserted-by":"publisher","first-page":"115","DOI":"10.36660\/abc.20211012","volume":"118","author":"GMM de Oliveira","year":"2022","unstructured":"de Oliveira GMM, Brant LCC, Polanczyk CA, Malta DC, Biolo A, Nascimento BR, et al. Cardiovascular statistics\u2014Brazil 2021 [in Portuguese]. Arq Bras Cardiol. 2022;118(1):115\u2013373.","journal-title":"Arq Bras Cardiol"},{"key":"405_CR22","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3389\/fphar.2012.00191","volume":"3","author":"G Suarez-Kurtz","year":"2012","unstructured":"Suarez-Kurtz G, Pena SD, Struchiner CJ, Hutz MH. Pharmacogenomic diversity among Brazilians: influence of ancestry, self-reported color, and geographical origin. Front Pharmacol. 2012;3:191.","journal-title":"Front Pharmacol"},{"issue":"8","key":"405_CR23","first-page":"839","volume":"94","author":"X Girerd","year":"2001","unstructured":"Girerd X, Radauceanu A, Achard JM, Fourcade J, Tournier B, Brillet G, et al. Evaluation of patient compliance among hypertensive patients treated by specialists [in French]. Arch Mal Coeur Vaiss. 2001;94(8):839\u201342.","journal-title":"Arch Mal Coeur Vaiss"},{"issue":"5","key":"405_CR24","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1161\/HYP.0000000000000087","volume":"73","author":"P Muntner","year":"2019","unstructured":"Muntner P, Shimbo D, Carey RM, Charleston JB, Gaillard T, Misra S, et al. Measurement of blood pressure in humans: a scientific statement from the American Heart Association. Hypertension. 2019;73(5):e35\u201366.","journal-title":"Hypertension"},{"issue":"4","key":"405_CR25","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"405_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0263932","volume":"17","author":"A Ajabnoor","year":"2022","unstructured":"Ajabnoor A, Mukhtar A. Effect of trimetazidine on the functional capacity of ischemic heart disease patients not suitable for revascularization: meta-analysis of randomized controlled trials. PLoS ONE. 2022;17(2): e0263932.","journal-title":"PLoS ONE"},{"issue":"2","key":"405_CR27","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000332369","volume":"120","author":"N Danchin","year":"2011","unstructured":"Danchin N, Marzilli M, Parkhomenko A, Ribeiro JP. Efficacy comparison of trimetazidine with therapeutic alternatives in stable angina pectoris: a network meta-analysis. Cardiology. 2011;120(2):59\u201372.","journal-title":"Cardiology"},{"issue":"7","key":"405_CR28","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1161\/CIRCULATIONAHA.121.054567","volume":"144","author":"J Mesnier","year":"2021","unstructured":"Mesnier J, Ducrocq G, Danchin N, Ferrari R, Ford I, Tardif JC, et al. International observational analysis of evolution and outcomes of chronic stable angina: the multinational CLARIFY study. Circulation. 2021;144(7):512\u201323.","journal-title":"Circulation"},{"issue":"1","key":"405_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2022.101420","volume":"48","author":"B Hansen","year":"2023","unstructured":"Hansen B, Holtzman JN, Juszczynski C, Khan N, Kaur G, Varma B, et al. Ischemia with No Obstructive Arteries (INOCA): a review of the prevalence, diagnosis and management. Curr Probl Cardiol. 2023;48(1): 101420.","journal-title":"Curr Probl Cardiol"},{"issue":"5","key":"405_CR30","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jacc.2022.08.814","volume":"81","author":"WE Boden","year":"2023","unstructured":"Boden WE, Marzilli M, Crea F, Mancini GBJ, Weintraub WS, Taqueti VR, et al. Evolving management paradigm for stable ischemic heart disease patients: JACC Review Topic of the Week. J Am Coll Cardiol. 2023;81(5):505\u201314.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"405_CR31","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.jacc.2012.02.082","volume":"60","author":"M Marzilli","year":"2012","unstructured":"Marzilli M, Merz CN, Boden WE, Bonow RO, Capozza PG, Chilian WM, et al. Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link! J Am Coll Cardiol. 2012;60(11):951\u20136.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"405_CR32","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/nrcardio.2017.131","volume":"15","author":"R Ferrari","year":"2018","unstructured":"Ferrari R, Camici PG, Crea F, Danchin N, Fox K, Maggioni AP, et al. Expert consensus document: a \u201cdiamond\u201d approach to personalized treatment of angina. Nat Rev Cardiol. 2018;15(2):120\u201332.","journal-title":"Nat Rev Cardiol"},{"key":"405_CR33","unstructured":"Laborat\u00f3rios Servier do Brasil Ltda. Summary of product characteristics\u2014Vastarel. 2023. https:\/\/servier.com.br\/wp-content\/uploads\/2023\/11\/23.11.07_Vastarel-caps-LP_Bula-do-profissional.pdf. Cited 1 July 2024."},{"issue":"216","key":"405_CR34","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ijcard.2016.04.082","volume":"1","author":"ER Weeda","year":"2016","unstructured":"Weeda ER, Coleman CI, McHorney CA, Crivera C, Schein JR, Sobieraj DM. Impact of once- or twice-daily dosing frequency on adherence to chronic cardiovascular disease medications: a meta-regression analysis. Int J Cardiol. 2016;1(216):104\u20139.","journal-title":"Int J Cardiol"},{"issue":"5","key":"405_CR35","doi-asserted-by":"publisher","first-page":"E18","DOI":"10.1016\/S0002-8703(03)00415-0","volume":"146","author":"G Fragasso","year":"2003","unstructured":"Fragasso G, Piatti Md PM, Monti L, Palloshi A, Setola E, Puccetti P, et al. Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy. Am Heart J. 2003;146(5):E18.","journal-title":"Am Heart J"}],"container-title":["Cardiology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-025-00405-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40119-025-00405-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-025-00405-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T02:48:44Z","timestamp":1747450124000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40119-025-00405-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["405"],"URL":"https:\/\/doi.org\/10.1007\/s40119-025-00405-9","relation":{},"ISSN":["2193-8261","2193-6544"],"issn-type":[{"value":"2193-8261","type":"print"},{"value":"2193-6544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"6 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Lu\u00eds Henrique Wolff Gowdak has received payments or honoraria from Servier and Novartis, support for attending meetings and\/or travel from Servier, and has served on a data safety monitoring board and advisory board for Servier. Elizabeth do Esp\u00edrito Santo Cest\u00e1rio has received payments for lectures given at events sponsored by Laborat\u00f3rio Servier do Brasil. Paulo Magno Martins Dourado, Dalton Bertolim Pr\u00e9coma, C\u00e9sar de Oliviera Lopes Dusilek, Francisco Maia da Silva, Juan Carlos Yugar-Toledo, Felipe Montes Pena, Domingos Ant\u00f4nio de Almeida Gomes, Olavo Raimundo Guimar\u00e3es Jr, Conrado Roberto Hoffmann Filho, Carlos Filinto de Almeida, Fl\u00e1vio de Souza Brito, Gerez Fernandes Martins, and Victor Rodrigues Ribeiro Ferreira declare no potential competing interests. Marcella Chaves Flores and Mayara L\u00eddia da Silva are currently employed by Servier Brazil.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was performed in accordance with good clinical practice and the ethical principles derived from the revised Declaration of Helsinki. The Institutional Review Board of the National Coordinator Centre (Instituto do Cora\u00e7\u00e3o, Hospital das Cl\u00ednicas, Faculdade de Medicina, Universidade de S\u00e3o Paulo, S\u00e3o Paulo, Brazil [4.884.990, approved on August 4, 2021]) approved the study protocol before the start of the study. The STROBE guidelines were used in reporting this study []. Participants provided written informed consent prior to their enrollment in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}